Sale by HENDERSON MICHAEL THOMAS (Chief Executive Officer)
20,000 shares · @ $82.09 · $1,641,711
Apogee Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $79.30
-4.2% in 7d after detection
Post-detection moves
1h
—
1d
-2.9%
3d
+0.3%
7d
-4.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS